Latest filing published 12 Nov 2009 for First Advantage CORP.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
FirstMark Capital, L.L.C.: trading record in brief
This profile gathers the share dealings of FirstMark Capital, L.L.C. across 2 companies, led by MAP Pharmaceuticals, Inc. and First Advantage Corp. In total, 318 filings cover trades dated from 12 December 2008 to 10 November 2009.
The open-market side counts 1 purchase for €4,018 alongside 316 sales for €5.0M. On balance, insiders were net sellers of €5.0M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2009, the count stands at 1 purchase and 315 sales.
The record was last updated on 12 November 2009 with a transaction in First Advantage Corp. The last insider purchase was made public on 23 June 2009, 6,347 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to FirstMark Capital, L.L.C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,092,130 sharesClass A Common StockSEC:0001455824-09-000017:0
- 740 shares@ US$10.50Common StockSEC:0001455824-09-000016:0
- 1,200 shares@ US$10.51Common StockSEC:0001455824-09-000016:1
- 2,116 shares@ US$10.52Common StockSEC:0001455824-09-000016:2
- 100 shares@ US$10.54Common StockSEC:0001455824-09-000016:3
- 1,600 shares@ US$10.55Common StockSEC:0001455824-09-000016:4
- 200 shares@ US$10.56Common StockSEC:0001455824-09-000016:5
- 284 shares@ US$10.57Common StockSEC:0001455824-09-000016:6
- 400 shares@ US$10.59Common StockSEC:0001455824-09-000016:7
- 200 shares@ US$10.60Common StockSEC:0001455824-09-000016:8
- 200 shares@ US$10.63Common StockSEC:0001455824-09-000016:9
- 600 shares@ US$10.64Common StockSEC:0001455824-09-000016:10
- 100 shares@ US$10.65Common StockSEC:0001455824-09-000016:11
- 100 shares@ US$10.66Common StockSEC:0001455824-09-000016:12
- 300 shares@ US$10.67Common StockSEC:0001455824-09-000016:13
- 200 shares@ US$10.69Common StockSEC:0001455824-09-000016:14
- 100 shares@ US$10.71Common StockSEC:0001455824-09-000016:15
- 300 shares@ US$10.72Common StockSEC:0001455824-09-000016:16
- 960 shares@ US$10.50Common StockSEC:0001455824-09-000016:17
- 1,700 shares@ US$12.00Common StockSEC:0001455824-09-000015:0
- 700 shares@ US$12.01Common StockSEC:0001455824-09-000015:1
- 9,452 shares@ US$12.00Common StockSEC:0001455824-09-000014:0
- 600 shares@ US$12.00Common StockSEC:0001455824-09-000014:1
- 1,468 shares@ US$12.01Common StockSEC:0001455824-09-000014:2
- 600 shares@ US$12.02Common StockSEC:0001455824-09-000014:3
25 of 303 declarations
